arrow
G

Grant A. McArthur

University of Melbourne
H指数:102
被引数:7.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tumor-resident T cells and dendritic cells form an in situ archetype during immunotherapy response in melanoma

肿瘤内T细胞和树突状细胞在黑色素瘤免疫治疗反应中形成原位原型

2026-06-010
PRE
Microbiota-derived butyrate promotes a FOXO1-induced stemness program and preserves CD8+ T cell immunity against melanoma

微生物组衍生的丁酸盐促进FOXO1诱导的干细胞特性程序,并维持CD8+ T细胞对黑色素瘤的免疫力

Immunity
IF26.3
2025-11-030
PRE
The development of a risk stratification tool for localized melanomas through the integrated application of supervised and unsupervised machine learning techniques

通过监督与无监督机器学习技术的集成应用,开发一种用于局部黑色素瘤的风险分层工具

2025-07-170
PRE
A plain language summary of POLARIS: a study to look at different doses of encorafenib plus binimetinib for people with BRAF V600-mutant melanoma with brain metastasis

POLARIS研究的简明语言摘要:一项针对BRAF V600突变黑色素瘤脑转移患者,评估encorafenib联合binimetinib不同剂量的研究

2025-05-260
OA
Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy
2024-11-010
PRE
Blending space and time to talk about cancer in extended reality
2024-09-290
OAAI
POLARIS: A phase 2 trial of encorafenib plus binimetinib evaluating high-dose and standard-dose regimens in patients with BRAF V600-mutant melanoma with brain metastasis

POLARIS: 一项2期试验,评估BRAF V600-mutant黑色素瘤脑转移患者的高剂量和标准剂量方案

2024-03-181
OAAI
The side effect registry immuno-oncology (SERIO) - A tool for systematic analysis of immunotherapy-induced side effects

副作用注册表免疫肿瘤学 (SERIO) -一种用于对免疫疗法引起的副作用进行系统分析的工具

2024-03-015
PRE
Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanoma
2023-11-251
OA